Biosynthetic collagen is the fastest growing segment fueling the growth of the Collagen Meniscus Implant Market
The global Collagen Meniscus Implant Market is estimated to be valued at US$ 470.7 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Collagen
meniscus implants are medical devices used to repair tears or defects in the
meniscus cartilage of the knee. They are made from highly purified collagen and
mimics the mechanical properties and biological structure of natural meniscus.
The biosynthetic collagen-based implants offers advantages such as better
biocompatibility, absorption into the body and regenerative ability compared to
allograft and synthetic scaffolds.
Market key trends:
Growing
use of biosynthetic collagen in implants is one of the major trends witnessed
in the market. Biosynthetic collagen is bioengineered using bovine or
recombinant collagen and offer benefits of natural collagen without concerns
regarding disease transmission or immune reactions. It provides enhanced biocompatibility
and promotes regeneration of injured meniscal tissues. Many companies are
focusing on development of innovative implants derived from biosynthetic
collagen to meet the increasing demand.
Segment Analysis
The Global
Collagen Meniscus Implant Market Size is segmented based on application
into medial meniscus and lateral meniscus. The medial meniscus segment
dominates the market due to the high incidence rate of injuries in the medial
meniscus. Around 75% of all meniscal tears occur in the medial meniscus making
it the largest segment.
Key Takeaways
The
global collagen meniscus implant market is expected to witness high growth,
exhibiting a CAGR of 4.4% over the forecast period, due to the increasing rate
of sports injuries and road accidents.
Regional analysis
North
America dominates the global market and is expected to grow at a high rate
owing to the rising sports injuries in the region and increasing reimbursement
coverage for knee surgeries. The Asia Pacific region is anticipated to be the
fastest-growing market due to growing healthcare infrastructure and rising
medical tourism in China and India.
Key players
Key players operating in the collagen meniscus implant market are Active
Implants, Stryker, RTI Surgical, CONMED, Zimmer Biomet, Smith & Nephew,
Arthrex, Biofixt, Ossur, MiMedx, and Bioventus. Active Implants dominates the
market with its innovative product ACTIVE Implant® Meniscus Scaffold.
Comments
Post a Comment